世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
個別化医療におけるナノ材料：世界市場Nanomaterials in Personalized Medicine: Global Markets レポートの範囲 本レポートでは、個別化医療市場におけるナノ材料の詳細な露出を提供する。本レポートでは、個別化医療におけるナノ材料の市場動向を、2022年からのデータ、2023年からの予測、2028年までの複... もっと見る
サマリーレポートの範囲本レポートでは、個別化医療市場におけるナノ材料の詳細な露出を提供する。本レポートでは、個別化医療におけるナノ材料の市場動向を、2022年からのデータ、2023年からの予測、2028年までの複合年間成長率の予測（予測期間は2023年から2028年。本レポートでは、個別化医療におけるナノ材料の現在と今後の市場可能性を、競合環境の詳細な分析とともに明らかにします。規制シナリオ、促進要因、阻害要因、機会を取り上げます。また、2028年の市場予測や主要市場プレイヤーの市場シェアについても取り上げます。 本レポートでは、市場の範囲を製品タイプと地域に区分しています。個別化医療におけるナノ材料の製品タイプはさらに、タンパク質、モノクローナル抗体、ナノ結晶、リポソーム、金ナノ粒子、量子ドットに区分される。個別化医療におけるナノ材料の地域市場分析は、北米、欧州、アジア太平洋、その他の地域（RoW）に区分される。地域セグメント内では、米国、ドイツ、英国、イタリア、フランス、日本、中国、インドなどの主要国の詳細な分析をカバーしています。市場予測については、2022年を基準年とし、2023年の推計値、2028年の予測値を掲載しています。 レポートは以下を含みます： - 27のデータ表と50の追加表 - 個別化医療におけるナノ材料の世界市場概要 - 2020年から2023年のデータを用いた市場規模の推定と世界市場動向の分析、2028年までの年間平均成長率（CAGR）の予測 - 現在および将来の市場ポテンシャルに関する考察、製品タイプ別および地域別市場の定量化 - バイオマーカー、ディープフェノタイピング、デジタルプレシジョンメディシン、遺伝学、医療情報技術などの新技術の説明、業界におけるESG動向と製薬エンドユーザーの持続可能性に関する議論 - モノクローナル抗体（mAbs）、ナノ結晶、リポソーム、ワクチン製造における使用法、量子ドットがナノキャリアとしてどのように機能するかについての考察など、様々な用語の詳細。 - 次世代ワクチン療法を用いたナノテクノロジーの進歩に関する洞察と、ヘルスケア分野への政府投資の概要。 - 国立ヒトゲノム研究所(NHGRI)およびその他の民間・政府投資によるプロジェクトや、サノフィがエクスクエンティアの革新的な二重特異性低分子化合物候補を導入したことに関する情報。 - 技術革新と技術進歩、精密医療の採用、規制シナリオ、市場促進要因、阻害要因、機会の評価 - 主要企業の市場シェア、独自技術、特許、パートナーシップ、提携、その他の主要戦略の分析 - ブリストル・マイヤーズ スクイブ社、エーザイ社、ギリアド・サイエンシズ社、イプセン・ファーマ社を含む業界主要企業の会社概要 目次Table of ContentsChapter 1 Introduction Overview of Nanotheranostics Polymeric Nanomaterials Magnetic Nanomaterials Silica-Based Nanomaterials Carbon Nanomaterials Composite Nanomaterials Biologic Nanomaterials: Antibody, Proteins and DNA Carbon Nanotubes Other Nanomaterials Multifunctional Nanomaterials Drug Delivery Study Goals and Objectives Reasons for Doing This Study Scope of Report What's New in this Update? Methodology Information Sources Geographic Breakdown Chapter 2 Summary and Highlights Market Outlook Market Insights Chapter 3 Market Overview Market Overview Theranostics and Personalized Medicines Overview Nanoparticles Passive Targeting Active Targeting Nanotechnology Overview Size Definition Shape Surface Area Nanotheranostic Drug Delivery In Vivo Drug-Release Studies Drug Efficacy Future Perspectives Chapter 4 Nanodevices and Nanomaterials in Diagnostics Overview Molecular Recognition in Diagnosis Nanopatterned Devices Particles Carbon Nanotubes Carbon Nanotubes as a Carriers of Immunoactive Compounds, Proteins and Genetic Materials Cancer Photothermal Therapy Carbon Nanotubes for Other Therapeutic Applications Fullerene C60 C60 Toxicity Uptake and Biodistribution Antioxidant Properties Endohedrals Magnetic Resonance Imaging Radionuclides Photodynamic Therapy DNA Photocleavage Cancer Enzymes, Viruses, and Bacteria Inhibition Drug and Gene Delivery Magnetic Nanoparticles Hyperthermia Magnetic Separation Imaging and Delivery Brain Tumor Delivery Prostate Cancer Bladder Tumors Quantum Dots Aptamer-Conjugated Nanoparticles Nanoparticle-Based Bio-Bar Codes Multiplex Dendrimers Surface Enhanced Raman Spectroscopy Diagnostic and Medical Device Industry Multifunctional Nanoparticles Polymeric Nanoparticles in Cancer Therapy Polymeric-Based Imaging Probes for Cancer Imaging Quantum Dots in Cancer Imaging and Therapy Quantum Dots in Photodynamic Therapy and Imaging Multifunctional Imaging Nanoparticles for Cancer Imaging and Therapy Magnetic Nanoparticles for Magnetic Resonance Imaging and Gene Delivery Multifunctional Magneto-Polymeric Nanohybrids for Cancer Imaging and Therapy Gold Nanoparticles for Photothermal Therapy Gold Nanoshells Gold Nanorods Magnetic Gold Nanoshells for Photothermal Therapy and Imaging Conclusion and Future Trends Chapter 5 Treatments Based on Nanomaterial for Infections Associated with Medical Devices Infections Associated with Medical Devices and Their Treatments Catheter-Associated Infections Soft-Tissue-Implant-Associated Infections Biofilm Formation Common Methods for Preventing and Treating Medical Device-Associated Infections Nanomaterials in Medical Applications Nanomaterials in Personalized Medicine Antimicrobial Nanomaterials Silver Nanoparticles Zinc Oxide Iron and Iron-Oxide Nanoparticles Titanium Oxide Carbon Nanotubes and Fullerenes Chitosan Cytotoxicity Consideration Chapter 6 Biomedical Nanoparticle Products Introduction Contract Manufacturing Organizations Information Technology Nanoparticle Drug Delivery Systems and Products Nanoparticle Drug Delivery Systems Company Pipelines for Nanoparticle Drug Delivery Chapter 7 Therapeutic and Diagnostic Companion Kits Introduction Chapter 8 Market Dynamics Market Drivers Rising Prevalence of Chronic Diseases Globally Rising Cancer Cases Globally Cancer Mortality Increasing Number of Diabetes Cases Worldwide Rising Worldwide Cases of Hypercholesterolemia Other major drivers in the personalized medicine market are: Market Restraints Challenges with Personalized Medicine Market Opportunities Nanodrug Delivery for the Treatment of Neurological Disorders Increasing Government Investment in Healthcare Sectors Rising Healthcare Costs Consumer Expectations Chapter 9 Regulatory Landscape Overview Physicochemical Properties of Nanoproducts Differ Compared to Their Larger Counterparts Regulatory Issues in Nanotechnology Nanomedicines in the Pharmaceutical Market Market Access and Pharmacoeconomics Chapter 10 Impact of COVID-19 on the Market Overview Structure of COVID-19 and Penetration COVID-19 Crisis Impact of COVID-19 on Nanomaterials in Personalized Medicine Novel Coronavirus Relying on Various Approaches Challenges in Vaccine Disruptions Components and Methods in the Design of a Vaccine Antigens Adjuvants Nanoparticles/Nanocarriers Devices Next-Generation Vaccines Enabled Through Advances in Nanotechnology Conclusions Regarding Use of Nanotechnology to Combat COVID-19 COVID-19 Measures Chapter 11 Market Breakdown by Product Type Market Overview Proteins Monoclonal Antibodies (mAbs) Monoclonal Antibody Therapy Mechanism Nanocrystals Nanocrystals Fabrication Liposomes Liposome Classification and Preparation Sonication Extrusion Freeze-Thawed Liposomes Solvent Dispersion Method Detergent-Removal Method Stealth Liposome Antibody-Liposome Conjugate Liposome Application in Medicine and Pharmacology Liposomes in Parasite Diseases and Infections Liposomes in Anticancer Therapies In Vitro Optical Imaging Gold Nanocarrier Hyperthermia Contrast Enhancers Radiotherapy Quantum Dots as Nanocarriers Photophysical Properties, Drug-Delivery and Drug-Release Sensing Visualizing Intracellular Uptake In Vitro Nanocarrier Biodistribution In Vivo Short Interfering RNA and DNA delivery Chapter 12 Market Breakdown by Region Overview North America U.S. Market Size and Forecast Canada Market Size and Forecast Europe Germany Market Size and Forecast U.K. Market Size and Forecast France Market Size and Forecast Italy Market Size and Forecast Spain Market Size and Forecast Rest of European Market Size and Forecast Asia-Pacific China Market Size and Forecast Japan Market Size and Forecast India Market Size and Forecast South Korea Market Size and Forecast Rest of Asia-Pacific Market Size and Forecast Rest of the World South America Market Size and Forecast Middle East and Africa Market Size and Forecast Chapter 13 ESG Development Introduction to ESG Environmental Social Government The Sustainability of Major Companies in the Industry Pharma End User Sustainability in the Industry Case Study Concluding Remarks from BCC Chapter 14 Emerging Technologies Overview Current Market Trends Emerging Technologies Biomarkers Deep Phenotyping Technologies Digital Precision Medicine Genetics Health Information Technology Chapter 15 Patents and Pipeline Analysis Overview Patent Analysis Pipeline Analysis Chapter 16 M&A Outlook M&A Analysis Major Strategic Alliances Chapter 17 Competitive Landscape Overview Distribution of Nanobiotechnology and Nanomedicine Companies Company Share Analysis Chapter 18 Company Profiles BRISTOL-MYERS SQUIBB CAMURUS AB CYTIMMUNE SCIENCES EISAI GILEAD SCIENCES INC. IPSEN PHARMA Chapter 19 Appendix: Acronyms
SummaryReport Scope: Table of ContentsTable of ContentsChapter 1 Introduction Overview of Nanotheranostics Polymeric Nanomaterials Magnetic Nanomaterials Silica-Based Nanomaterials Carbon Nanomaterials Composite Nanomaterials Biologic Nanomaterials: Antibody, Proteins and DNA Carbon Nanotubes Other Nanomaterials Multifunctional Nanomaterials Drug Delivery Study Goals and Objectives Reasons for Doing This Study Scope of Report What's New in this Update? Methodology Information Sources Geographic Breakdown Chapter 2 Summary and Highlights Market Outlook Market Insights Chapter 3 Market Overview Market Overview Theranostics and Personalized Medicines Overview Nanoparticles Passive Targeting Active Targeting Nanotechnology Overview Size Definition Shape Surface Area Nanotheranostic Drug Delivery In Vivo Drug-Release Studies Drug Efficacy Future Perspectives Chapter 4 Nanodevices and Nanomaterials in Diagnostics Overview Molecular Recognition in Diagnosis Nanopatterned Devices Particles Carbon Nanotubes Carbon Nanotubes as a Carriers of Immunoactive Compounds, Proteins and Genetic Materials Cancer Photothermal Therapy Carbon Nanotubes for Other Therapeutic Applications Fullerene C60 C60 Toxicity Uptake and Biodistribution Antioxidant Properties Endohedrals Magnetic Resonance Imaging Radionuclides Photodynamic Therapy DNA Photocleavage Cancer Enzymes, Viruses, and Bacteria Inhibition Drug and Gene Delivery Magnetic Nanoparticles Hyperthermia Magnetic Separation Imaging and Delivery Brain Tumor Delivery Prostate Cancer Bladder Tumors Quantum Dots Aptamer-Conjugated Nanoparticles Nanoparticle-Based Bio-Bar Codes Multiplex Dendrimers Surface Enhanced Raman Spectroscopy Diagnostic and Medical Device Industry Multifunctional Nanoparticles Polymeric Nanoparticles in Cancer Therapy Polymeric-Based Imaging Probes for Cancer Imaging Quantum Dots in Cancer Imaging and Therapy Quantum Dots in Photodynamic Therapy and Imaging Multifunctional Imaging Nanoparticles for Cancer Imaging and Therapy Magnetic Nanoparticles for Magnetic Resonance Imaging and Gene Delivery Multifunctional Magneto-Polymeric Nanohybrids for Cancer Imaging and Therapy Gold Nanoparticles for Photothermal Therapy Gold Nanoshells Gold Nanorods Magnetic Gold Nanoshells for Photothermal Therapy and Imaging Conclusion and Future Trends Chapter 5 Treatments Based on Nanomaterial for Infections Associated with Medical Devices Infections Associated with Medical Devices and Their Treatments Catheter-Associated Infections Soft-Tissue-Implant-Associated Infections Biofilm Formation Common Methods for Preventing and Treating Medical Device-Associated Infections Nanomaterials in Medical Applications Nanomaterials in Personalized Medicine Antimicrobial Nanomaterials Silver Nanoparticles Zinc Oxide Iron and Iron-Oxide Nanoparticles Titanium Oxide Carbon Nanotubes and Fullerenes Chitosan Cytotoxicity Consideration Chapter 6 Biomedical Nanoparticle Products Introduction Contract Manufacturing Organizations Information Technology Nanoparticle Drug Delivery Systems and Products Nanoparticle Drug Delivery Systems Company Pipelines for Nanoparticle Drug Delivery Chapter 7 Therapeutic and Diagnostic Companion Kits Introduction Chapter 8 Market Dynamics Market Drivers Rising Prevalence of Chronic Diseases Globally Rising Cancer Cases Globally Cancer Mortality Increasing Number of Diabetes Cases Worldwide Rising Worldwide Cases of Hypercholesterolemia Other major drivers in the personalized medicine market are: Market Restraints Challenges with Personalized Medicine Market Opportunities Nanodrug Delivery for the Treatment of Neurological Disorders Increasing Government Investment in Healthcare Sectors Rising Healthcare Costs Consumer Expectations Chapter 9 Regulatory Landscape Overview Physicochemical Properties of Nanoproducts Differ Compared to Their Larger Counterparts Regulatory Issues in Nanotechnology Nanomedicines in the Pharmaceutical Market Market Access and Pharmacoeconomics Chapter 10 Impact of COVID-19 on the Market Overview Structure of COVID-19 and Penetration COVID-19 Crisis Impact of COVID-19 on Nanomaterials in Personalized Medicine Novel Coronavirus Relying on Various Approaches Challenges in Vaccine Disruptions Components and Methods in the Design of a Vaccine Antigens Adjuvants Nanoparticles/Nanocarriers Devices Next-Generation Vaccines Enabled Through Advances in Nanotechnology Conclusions Regarding Use of Nanotechnology to Combat COVID-19 COVID-19 Measures Chapter 11 Market Breakdown by Product Type Market Overview Proteins Monoclonal Antibodies (mAbs) Monoclonal Antibody Therapy Mechanism Nanocrystals Nanocrystals Fabrication Liposomes Liposome Classification and Preparation Sonication Extrusion Freeze-Thawed Liposomes Solvent Dispersion Method Detergent-Removal Method Stealth Liposome Antibody-Liposome Conjugate Liposome Application in Medicine and Pharmacology Liposomes in Parasite Diseases and Infections Liposomes in Anticancer Therapies In Vitro Optical Imaging Gold Nanocarrier Hyperthermia Contrast Enhancers Radiotherapy Quantum Dots as Nanocarriers Photophysical Properties, Drug-Delivery and Drug-Release Sensing Visualizing Intracellular Uptake In Vitro Nanocarrier Biodistribution In Vivo Short Interfering RNA and DNA delivery Chapter 12 Market Breakdown by Region Overview North America U.S. Market Size and Forecast Canada Market Size and Forecast Europe Germany Market Size and Forecast U.K. Market Size and Forecast France Market Size and Forecast Italy Market Size and Forecast Spain Market Size and Forecast Rest of European Market Size and Forecast Asia-Pacific China Market Size and Forecast Japan Market Size and Forecast India Market Size and Forecast South Korea Market Size and Forecast Rest of Asia-Pacific Market Size and Forecast Rest of the World South America Market Size and Forecast Middle East and Africa Market Size and Forecast Chapter 13 ESG Development Introduction to ESG Environmental Social Government The Sustainability of Major Companies in the Industry Pharma End User Sustainability in the Industry Case Study Concluding Remarks from BCC Chapter 14 Emerging Technologies Overview Current Market Trends Emerging Technologies Biomarkers Deep Phenotyping Technologies Digital Precision Medicine Genetics Health Information Technology Chapter 15 Patents and Pipeline Analysis Overview Patent Analysis Pipeline Analysis Chapter 16 M&A Outlook M&A Analysis Major Strategic Alliances Chapter 17 Competitive Landscape Overview Distribution of Nanobiotechnology and Nanomedicine Companies Company Share Analysis Chapter 18 Company Profiles BRISTOL-MYERS SQUIBB CAMURUS AB CYTIMMUNE SCIENCES EISAI GILEAD SCIENCES INC. IPSEN PHARMA Chapter 19 Appendix: Acronyms
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（その他）の最新刊レポート
BCC Research 社の最新刊レポート本レポートと同じKEY WORD（personalized medicine）の最新刊レポートよくあるご質問BCC Research社はどのような調査会社ですか?BCCリサーチ（BCC Research）は1971年に設立され、様々な業界経験を持つアナリストと編集者によりトップクラスの市場情報源を長年提供している調査会社です。 設立初期は先端材料とプラ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/07/05 10:26 162.17 円 175.82 円 209.73 円 |
